Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 50 | 40 | 65 | 46 | 42 |
| Cost of Goods | 8 | 8 | 12 | 30 | N/A |
| Gross Profit | 42 | 32 | 53 | 16 | 42 |
| Operating Expenses | 3,744 | 5,774 | 14,068 | 8,203 | 5,503 |
| Operating Income | -3,694 | -5,734 | -14,003 | -8,157 | -5,461 |
| Interest Expense | 179 | 72 | 0 | 0 | 0 |
| Other Income | 2,037 | -11 | 1,427 | 341 | 552 |
| Pre-tax Income | -1,836 | -5,817 | -12,576 | -7,816 | -4,909 |
| Net Income Continuous | -1,836 | -5,817 | -12,576 | -7,816 | -4,909 |
| Net Income | $-1,836 | $-5,817 | $-12,576 | $-7,816 | $-4,909 |
| EPS Basic Total Ops | -3.00 | -12.00 | -26.00 | -16.00 | -10.00 |
| EPS Basic Continuous Ops | -3.47 | -11.76 | -25.84 | -16.07 | -10.14 |
| EPS Diluted Total Ops | -3.00 | -12.00 | -26.00 | -16.00 | -10.00 |
| EPS Diluted Continuous Ops | -3.47 | -11.76 | -25.84 | -16.07 | -10.14 |
| EPS Diluted Before Non-Recurring Items | -3.00 | -12.00 | -26.00 | N/A | N/A |
| EBITDA(a) | $-3,436 | $-5,603 | $-13,945 | $-8,090 | $-5,381 |